Atom Investors »

Lenz Therapeutics shares owned by Atom Investors

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Atom Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $181k 32k 5.68

More positions owned by Atom Investors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Viatris (VTRS)
Intel Corporation (INTC)
Hewlett Packard Enterprise (HPE)
Rhythm Pharmaceuticals (RYTM)
Esab Corporation (ESAB)
Ishares Msci Brazil Etf (EWZ)
Gxo Logistics Incorporated Common Stock (GXO)
Applied Materials (AMAT)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
VSE Corporation (VSEC)
Apple (AAPL)
Immunome (IMNM)
John Bean Technologies Corporation (JBTM)

View all positions for Atom Investors

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
FMR
Versant Venture Management
BlackRock
Squarepoint Ops
Standard Life Aberdeen
Millennium Management
Vanguard Capital Management
72 Investment Holdings
Blue Owl Capital Holdings
CAM Group Holding A/S
Morgan Stanley
Citadel Advisors
Geode Capital Management

View all funds holding Lenz Therapeutics